Showing results (101-110 of 325) with videos related to
Sort By:
Pageof 33
Journal of Virology|February 1, 2005
Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse modelHirotomo Nakata, Kenji Maeda, Toshikazu Miyakawa, et al.Cell Chemical Biology|September 4, 2018
The High Genetic Barrier of EFdA/MK-8591 Stems from Strong Interactions with the Active Site of Drug-Resistant HIV-1 Reverse TranscriptaseYuki Takamatsu, Debananda Das, Satoru Kohgo, et al.The Journal of Infectious Diseases|February 28, 2002
Genetic evidence of transmission of human T cell lymphotropic virus type 1 between spousesMutsunori Iga, Akihiko Okayama, Sherri Stuver, et al.Bioorganic & Medicinal Chemistry Letters|January 5, 2002
Increase of the adenallene anti-HIV activity in cell culture using its bis(tBuSATE) phosphotriester derivativeDavid Egron, Christian Périgaud, Gilles Gosselin, et al.Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Tryptophanyl phosphoramidates as prodrugs of synadenol and its E-isomer: synthesis and biological activityRuifang Wang, Thomas H Corbett, Yung-Chi Cheng, et al.Antimicrobial Agents and Chemotherapy|December 14, 2011
Mechanism of interaction of human mitochondrial DNA polymerase γ with the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine indicates a low potential for host toxicityChristal D Sohl, Kamlendra Singh, Rajesh Kasiviswanathan, et al.Virology|September 8, 2004
Novel patterns of nevirapine resistance-associated mutations of human immunodeficiency virus type 1 in treatment-naïve patientsAtsuko Hachiya, Hiroyuki Gatanaga, Eiichi Kodama, et al.Journal of Medicinal Chemistry|September 29, 2006
9-{[3-fluoro-2-(hydroxymethyl)cyclopropylidene]methyl}adenines and -guanines. Synthesis and antiviral activity of all stereoisomers1Shaoman Zhou, Earl R Kern, Elizabeth Gullen, et al.Antimicrobial Agents and Chemotherapy|January 14, 2015
Insights into the mechanism of inhibition of CXCR4: identification of Piperidinylethanamine analogs as anti-HIV-1 inhibitorsDebananda Das, Kenji Maeda, Yasuhiro Hayashi, et al.Global Health & Medicine|December 17, 2020
A novel HIV-1 protease inhibitor, GRL-044, has potent activity against various HIV-1s with an extremely high genetic barrier to the emergence of HIV-1 drug resistanceManabu Aoki, Simon B Chang, Debananda Das, et al.Pageof 33